Fairvalue-Calculator Fairvalue-Calculator
EN DE

Rhone Ma Holdings (5278) Fair Value & Analysis

Healthcare · MY · Market cap 146M MYR

Price0.6450 MYR
Fair Value1.40 MYR
Upside+117.1%
Quality95/100
Evidence: High Range 1.05 MYR – 1.76 MYR

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Rhone Ma Holdings (5278) currently trades at 0.6450 MYR, while our model-based Fair Value estimate is 1.40 MYR — implying the stock looks roughly 117.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company operates through Animal Health Products and Food Equipment; Food Ingredients; and others segments. It offers diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services, as well as trades in animal health products. The company also undertakes research and development activities related to animal health, food safety, and agriculture; distributes human healthcare and related products; wholesales and distributes pharmaceutical and veterinary products, including animal feeds; and distributes and supplies food ingredients to manufacturers of food and beverage industries. In addition, the company involved in the raising, breeding, and production of semi-domestic…

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Rhone Ma Holdings (5278) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 1.40 MYR versus a price of 0.6450 MYR — about +117% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 5278?
Our 21-model fair value for Rhone Ma Holdings is 1.40 MYR (as of Jun 25, 2026), built from audited fundamentals. The current price is 0.6450 MYR.
What is the quality score of 5278?
Rhone Ma Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.